Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPrime Medicine, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.45 | -$0.45 | -$0.45 |
| Q2 2024 | 3 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2024 | 3 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2024 | 8 | -$0.49 | -$0.31 | -$0.40 |
| Q1 2025 | 4 | -$0.46 | -$0.25 | -$0.35 |
| Q2 2025 | 2 | -$0.36 | -$0.36 | -$0.36 |
| Q3 2025 | 2 | -$0.36 | -$0.36 | -$0.36 |
| Q4 2025 | 2 | -$0.39 | -$0.39 | -$0.39 |
| Q1 2026 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q2 2026 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q3 2026 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q4 2026 | 1 | -$0.45 | -$0.45 | -$0.45 |
Prime Medicine, Inc. Earnings Date And Information
Prime Medicine, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.44 earnings per share for the quarter, missing analysts' consensus estimates of $-0.43 by $0.01. The company had revenue of 209,000 for the quarter and had revenue of 0 for the year. Prime Medicine, Inc. has generated $-2 earnings per share over the last year ($-2.18 diluted earnings per share) and currently has a price-to-earnings ratio of -1.52. Prime Medicine, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Prime Medicine, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.43 | -$0.44 | -0.01 | $7.09 M | $209,000 |
| 08/08/2024 | Q2 2024 | -$0.40 | -$0.46 | -0.06 | $1.63 M | $37.77 M |
| 05/10/2024 | Q1 2024 | -$0.45 | -$0.44 | 0.01 | $591,000 | |
| 03/01/2024 | Q4 2023 | -$0.48 | -$0.67 | -0.19 | $0 | |
| 11/03/2023 | Q3 2023 | -$0.45 | -$0.55 | -0.1 | $1.67 M | $0 |
| 08/07/2023 | Q2 2023 | -$0.42 | -$0.47 | -0.05 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.42 | -$0.44 | -0.02 | $0 | |
| 03/09/2023 | Q4 2022 | -$0.65 | -$0.56 | 0.09 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.38 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.50 | $0 | |||
| 03/30/2022 | Q1 2022 | -$0.42 | $0 | |||
| 12/30/2021 | Q4 2021 | -$0.96 | $0 | |||
| 09/29/2021 | Q3 2021 | -$0.32 | $0 | |||
| 06/30/2021 | Q2 2021 | -$0.04 | $9.13 M | |||
| 03/31/2021 | Q1 2021 | -$12.15 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.04 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.04 | $0 |
Prime Medicine, Inc. Earnings: FAQ's
When is Prime Medicine, Inc.'s earnings date?
Prime Medicine, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based off last year's report dates.
How can I listen to Prime Medicine, Inc.'s earnings conference
call?
The conference call for Prime Medicine, Inc.'s latest earnings report can be listened to online.
How can I read Prime Medicine, Inc.'s conference call transcript?
The conference call transcript for Prime Medicine, Inc.'s latest earnings report can be read online.
How much profit does Prime Medicine, Inc. generate each year?
Prime Medicine, Inc. (:PRME) has a recorded net income of $0. Prime Medicine, Inc. has generated $-2.18 earnings per share over the last four quarters.
What is Prime Medicine, Inc.'s price-to-earnings ratio?
Prime Medicine, Inc. (:PRME) has a price-to-earnings ratio of -1.52 and price/earnings-to-growth ratio is -0.29.